GlaxoSmithKline K.K. Posted June 8, 2026

Evidence Strategy & Operations Lead

Akasaka, Japan Full time
Health Economics & Outcomes Research

GlaxoSmithKline K.K. is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

Job Purpose 

At GSK, we are uniting science, technology, and talent to get ahead of disease together. The Evidence Generation

Strategy & Operations Lead is responsible to provide DGP process coordination and study/ project management,

statistic & data management expertise for studies in Japan CPO to ensure the delivery of evidence generation to

support launch readiness, pricing, reimbursement and life cycle management. The role will also partner closely with

the Japan Head of RWE-HO to ensure timely planning and tracking for enterprise strategic and capability building

initiatives, ensuring excellence of teams.

Key Responsibilities 

Reporting directly to the Japan Head of Real-World Evidence & Health Outcomes, the role will:

• Shape evidence-generation strategy across therapeutic areas and drive cross-portfolio operational synergies.

• Acts as leader to enterprise evidence strategy and operations, covering aspects of evidence synthesis,

analytics and study operations to provide coaching and implement internal standards and processes.

• Responsible for the timing and quality delivery of the study/ projects and organize the regular study

monitor meeting for dashboard management.

• Ensures study quality standards, i.e. no significant compliance (GCP, SOP or applicable regulations)

issue throughout study planning and execution.

• Redefine processes and ways of working to enable more efficient and effective planning and execution

of data-generation programs, standardizing workflows, reducing duplication and accelerating delivery

across the portfolio.

• Responsible for the quality of outsource service through vendor management.

• Maintains effective communication with internal and external stakeholders.

• Proactively identify and drive cross-TA and cross-portfolio synergies (e.g., data reuse, harmonized study

designs, shared analytics) to increase efficiency, reduce duplication and accelerate timelines.

• Represents Japan RWE-HO in cross-regional forums on evidence strategy, ensuring alignment with

global RWE-HO initiatives and facilitating two-way knowledge transfer.

• Partners closely with Global RWE-HO to prepare QBRs and townhalls, and to promote best-practice

sharing in Japan and across other regions.

Experience and Qualifications 

• Advanced degree in a relevant field (e.g., Epidemiology, Biostatistics, Public Health, Life Sciences)

preferred.

• Significant experience in real-world evidence, clinical or observational study design, statistical or data

management, and study delivery.

• Demonstrated people management and cross-functional leadership skills.

• Experience with vendor management and quality/compliance oversight in regulated environments.

• Strong communication, project management and problem-solving skills.

• Consulting/ CRO managerial experience welcomed.

※職務内容および勤務地の変更範囲は会社の定めるところとする。

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

We are committed to creating an inclusive workplace and providing equal opportunities for all applicants. We embrace an agile working culture across our roles, so if flexibility is important to you please discuss opportunities with our hiring team. If you need any adjustments to the recruitment process to help you demonstrate your strengths and capabilities, contact [email protected] . Please note this email is for adjustment requests only; for other enquiries please use our standard contact channels.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Job details

Seniority
Not listed
Function
Health Economics & Outcomes Research
Therapeutic area
Not listed
Location
Akasaka, Japan
Employment type
Full time

How this role compares

Computed from every other active Health Economics & Outcomes Research role in our database, not just this employer's listings.

We currently track 12 comparable Health Economics & Outcomes Research roles across 3 biopharma companies.

12Comparable roles tracked
8Currently active
3Companies hiring similar roles
4Countries represented

Salary context

2 of 12 peers report a salary range (USD, annualized)

Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.

This roleSubject Not listed on this posting
Lowest disclosed · Director, Patient Centered Science, Late CVRM · AstraZeneca $194,147/yr – $291,220/yr
Peer group range $242,684 – $271,700 (median $257,192)

Where these roles are based

Top locations among the 12 comparable roles

United States7
Japan3
United Kingdom1
Germany1

Seniority mix

11 of 12 peers have a known seniority level

Director5
Associate Director3
Senior Director2
Manager1

Therapeutic area mix

7 of 12 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology4
Vaccines & Infectious Disease1
Respiratory1
Cardiovascular / CVRM1

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

40%similar
GlaxoSmithKline K.K. Akasaka, Japan Associate Director
Same function Same country
40%similar
GlaxoSmithKline K.K. Akasaka, Japan Manager
Same function Same country
40%similar
GlaxoSmithKline K.K. Akasaka, Japan Director
Same function Same country
25%similar
AstraZeneca Gaithersburg, Maryland, United States of America Associate Director
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

25%similar
GlaxoSmithKline LLC Philadelphia, United States Director
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

25%similar
GlaxoSmithKline LLC Upper Providence, United States Director
Same function

Matched on job function only -- seniority, specialty, and location weren't confirmed as aligned.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

40%
Associate Director/Scientist, Japan Real-World Evidence & Health Outcomes Research
GlaxoSmithKline K.K. · Akasaka, Japan · Associate Director
Function Therapeutic area Seniority Country
25%
Associate Director, Oncology Outcomes Research
AstraZeneca · Gaithersburg, Maryland, United States of America · Associate Director
Function Therapeutic area Seniority Country
25%
Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines
GlaxoSmithKline LLC · Philadelphia, United States · Senior Director
Function Therapeutic area Seniority Country
25%
Associate Director, Safety Epidemiology – Global Patient Safety
AstraZeneca · Luton, Bedfordshire, United Kingdom · Associate Director
Function Therapeutic area Seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.